22nd Century Group falls after reverse stock split announcement
** Shares of biotech co 22nd Century Group Inc XXII.O down
8% at $0.35, premarket
** Co announces reverse stock split of its outstanding
shares of common stock at ratio of 1-for-15; to be effective on
July 5
** Reverse stock split is intended for co to regain
compliance with minimum bid price requirement for continued
listing on Nasdaq
** XXII shares down ~60% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on 22nd Century
See all newsNASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: FDA To Review Two Modified Risk Tobacco Product Renewal Applications From 22nd Century Group
22nd Century Group Q4 losses narrow on market expansion, improved margins